← Leaderboards
Eduard A. Sergienko
Mayo Clinic Arizona
$20,721,252
Attributed
$28,470,365
Total exposure
9
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.3M · FY2008–25$5M$3.8M$2.5M$1.3M$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$28,470,365 · 9
By mechanism
R01$15,724,141 · 8
U54$12,746,224 · 1
Top collaborators
- Gary L. Kleiger5 shared
- Senthil Kumar Radhakrishnan5 shared
- Robert Ardecky4 shared
- Laurence J Miller4 shared
- Elena B Pasquale4 shared
- Douglas Faigel3 shared
- Taro Hitosugi3 shared
- Steven H Olson2 shared
Most similar at Mayo Clinic Arizona
Same institution · by research overlap
- Laurence J Miller$18,092,149
- Robert Ardecky$767,106
- Douglas Faigel$980,049
Others in their field
Top investigators on “Analog”
- David Heimbrook · Leidos Biomedical Research, Inc.$196,589,777
- Constance Ann Benson · University Of California, San Diego$84,289,569
- Norman Wolmark · Nsabp Foundation, Inc.$51,982,954
- Robert Turner Schooley · University Of Colorado Denver$48,513,949
- Kenneth A Bloom · University Of Nebraska-Lincoln$46,979,168
- John Hobbs · Suny At Stony Brook$41,239,084
Research focus
AnalogScaffoldValidationHigh Throughput ScreeningFutureResponseCellsScreeningDoseProteinsBindingSmall MoleculePathway InteractionsBiochemicalPowder Dose FormCancer CellInhibitorPharmaceutical PreparationsClinical TrialsScale UpCheminformaticsAffectProductionEnzymes
Grant awards (31)
Discovery of Potent Selective Inhibitors of the Histone Methyltransferase SUV39H1 for the Treatment of Cancer$809,248
R01 · FY2025 · CA
Screening for Inhibitors of the Chromatin Reader SGF29$768,437
R01 · FY2025 · CA
Identification of small molecule inhibitors of the DDI2 protease$699,304
R01 · FY2025 · CA
Discovery of Glutaryl-CoA Dehydrogenase inhibitors for melanoma and pancreatic cancer$538,890
R01 · FY2025 · CA · contact PI
Activation of the Secretin Receptor as a Strategy for the Treatment of Heart Failure$454,632
R01 · FY2025 · HL
Identification of small molecule inhibitors of the DDI2 protease$77,925
R01 · FY2025 · CA
Discovery of Potent Selective Inhibitors of the Histone Methyltransferase SUV39H1 for the Treatment of Cancer$809,234
R01 · FY2024 · CA
Identification of small molecule inhibitors of the DDI2 protease$671,643
R01 · FY2024 · CA
Activation of the Secretin Receptor as a Strategy for the Treatment of Heart Failure$631,842
R01 · FY2024 · HL
Discovery of Glutaryl-CoA Dehydrogenase inhibitors for melanoma and pancreatic cancer$577,198
R01 · FY2024 · CA · contact PI
Identification of small molecule inhibitors of the DDI2 protease$77,925
R01 · FY2024 · CA
Discovery of Selective Inhibitors for the EphA4 Kinase$760,964
R01 · FY2023 · AG · contact PI
Identification of small molecule inhibitors of the DDI2 protease$730,979
R01 · FY2023 · CA
Activation of the Secretin Receptor as a Strategy for the Treatment of Heart Failure$605,207
R01 · FY2023 · HL
Discovery of Glutaryl-CoA Dehydrogenase inhibitors for melanoma and pancreatic cancer$599,074
R01 · FY2023 · CA · contact PI
Discovery of Selective Inhibitors for the EphA4 Kinase$757,556
R01 · FY2022 · AG · contact PI
Activation of the Secretin Receptor as a Strategy for the Treatment of Heart Failure$609,636
R01 · FY2022 · HL
Discovery of Glutaryl-CoA Dehydrogenase inhibitors for melanoma and pancreatic cancer$569,944
R01 · FY2022 · CA · contact PI
Identification of small molecule modulators of mitochondrial creatine kinase 1$491,439
R01 · FY2022 · CA · contact PI
Discovery of Selective Inhibitors for the EphA4 Kinase$754,237
R01 · FY2021 · AG · contact PI
Identification of small molecule modulators of mitochondrial creatine kinase 1$496,612
R01 · FY2021 · CA · contact PI
Discovery of Selective Inhibitors for the EphA4 Kinase$751,756
R01 · FY2020 · AG · contact PI
Identification of small molecule modulators of mitochondrial creatine kinase 1$520,361
R01 · FY2020 · CA · contact PI
High Throughput Screening to Discover Chemical Inhibitors of Quiescin Sulfhydryl Oxidase 1$648,006
R01 · FY2018 · CA
High Throughput Screening to Discover Chemical Inhibitors of Quiescin Sulfhydryl Oxidase 1$678,423
R01 · FY2017 · CA
High Throughput Screening to Discover Chemical Inhibitors of Quiescin Sulfhydryl Oxidase 1$633,669
R01 · FY2016 · CA
Assay Development$2,625,600
U54 · FY2012 · HG · contact PI
Assay Development$2,631,289
U54 · FY2011 · HG · contact PI
Assay Development$2,536,221
U54 · FY2010 · HG · contact PI
Assay Development$2,557,977
U54 · FY2009 · HG · contact PI
Assay Development$2,395,137
U54 · FY2008 · HG · contact PI